News Archive

Walbrook PR supports trio of stock exchange admissions

20 May 2020

Walbrook PR Limited, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has supported the admissions of three companies to the UK’s public stockmarkets since the turn of the year, with OTAQ plc the latest to announce the commencement of dealings in its shares on the London Stock Exchange’s Main Market.

OTAQ plc - https://otaq.com/

OTAQ plc is an innovative marine technology company focused on the global aquaculture, offshore energy, renewables and oceanographic research sectors. The Company completed a reverse takeover of cash shell, Hertsford Capital, and OTAQ shares were admitted to trading on the Main Market of the London Stock Exchange on the 31st March. OTAQ has raised £1.5m through an equity placing at 57.5p and had a market capitalisation on admission of £17.6m. OTAQ’s main system, Sealfence™, is a Finfish farming predator deterrent device, with systems deployed in Scotland, Chile, Finland and Russia.

[email protected] Capital plc - www.supplymecapital.com

[email protected] is an Italian-based alternative FinTech platform providing innovative inventory financing facilities, enabling a wide range of manufacturing and trading businesses to monetise the capital tied up in their nventories and thus improve their working capital positions. The Company reversed into AIM shell, Abal Group plc, and its shares were admitted to trading on the Standard Segment of the LSE’s Main Market on 23 March 2020. Its current market capitalisation is approximately  £100m. Shares trade with the TIDM: SYSE

Greencare Capital plc - https://www.greencare.capital/

Greencare Capital plc is an investment vehicle identifying opportunities to invest in or acquire those businesses operating within the legal Medicinal Cannabis market with its rapidly evolving regulatory environment. It is also seeking investment opportunities within the Hemp and CBD wellness sectors and other plant-based medicines. The Company was admitted onto the NEX Exchange (now Aquis Stock Exchange) on 30 December 2019, with a market capitalisation of £5m.

Paul McManus, Founder & MD of Walbrook, commented: The Walbrook team is delighted to support these transactions, and equally importantly, to providing ongoing expert, proactive communications advice and investor relations services. With a dearth of companies coming to public markets during these challenging times, it is very important to be able to play such an active role in so many recent new public listings. Despite current market uncertainties,Walbrook remains very much open for business and will continue to offer growth companies the best Financial PR and IR support.”

 

For further information please contact:

Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

[email protected]


About Walbrook PR
www.walbrookpr.com

Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM listed companies.

Walbrook PR is ranked 3rd in the Corporate Advisers Rankings Guide and is ranked 8th by total number of Stock Market listed clients. Walbrook acts for 47 listed companies across a wide mix of sectors.

Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM listed companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.

Who We Work With